AM
Insider
Alan Mateo
DirectorAlan Mateo (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in 10x Genomics, Inc. (TXG). Across 1 priced purchase filing, the average 21-session return was -10.5% from execution and -13.4% from disclosure (delay-adjusted; derived). The largest single filing was $446K of TXG (40,000 sh × $11.14, as filed), executed Feb 21 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
-10.5%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
-13.4%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
4d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$446K
shares × price, as filed
Last traded
Feb 21 2025
Filed Feb 25 2025
Median ADV $190.4M across their filed names
Open performance→Volume by month
Buys $446K
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
TXGRecent filings
TXGPURCHASE
10x Genomics, Inc.
View filing →
$446K40,000 sh × $11.14
Exec Feb 21 2025
Filed Feb 25 2025 · 5:30 PM ET